The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.

Ann E Woolley,Aditya R Gandhi, Michelle L Jones,Jane J Kim,Hari R Mallidi,Michael M Givertz,Lindsey R Baden,Mandeep R Mehra,And Anne M Neilan

Transplantation（2023）

引用 1|浏览17

暂无评分

摘要

Transplanting hearts from HCV-infected donors could decrease waitlist times, increase life expectancy, and be cost-effective. These findings were robust within the context of current high HCV treatment costs.

查看译文

关键词

donors,hearts,cost-effectiveness,c-infected

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要